Current status and progress of prepandemic and pandemic influenza vaccine development
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Current status and progress of prepandemic and pandemic influenza vaccine development
Authors
Keywords
-
Journal
Expert Review of Vaccines
Volume 8, Issue 4, Pages 401-423
Publisher
Informa UK Limited
Online
2009-04-06
DOI
10.1586/erv.09.15
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults
- (2009) Angelika Banzhoff et al. PLoS One
- Prepandemic Influenza Vaccine H5N1 (Split Virion, Inactivated, Adjuvanted) [Prepandrix™]
- (2008) Natalie J Carter et al. BIODRUGS
- Pandemic H5N1 influenza vaccine development: an update
- (2008) Hana M El Sahly et al. Expert Review of Vaccines
- Vaccines against Influenza A (H5N1): Evidence of Progress
- (2008) Gregory A. Poland et al. JOURNAL OF INFECTIOUS DISEASES
- An Adjuvanted, Low‐Dose, Pandemic Influenza A (H5N1) Vaccine Candidate Is Safe, Immunogenic, and Induces Cross‐Reactive Immune Responses in Healthy Adults
- (2008) Karin Levie et al. JOURNAL OF INFECTIOUS DISEASES
- Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in Adults
- (2008) David I. Bernstein et al. JOURNAL OF INFECTIOUS DISEASES
- Antibody Persistence after 2‐Dose Priming and Booster Response to a Third Dose of an Inactivated, Adjuvanted, Whole‐Virion H5N1 Vaccine
- (2008) Jiang‐Tao Lin et al. JOURNAL OF INFECTIOUS DISEASES
- Human infection with highly pathogenic H5N1 influenza virus
- (2008) Andrea Gambotto et al. LANCET
- Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans
- (2008) Lance C Jennings et al. LANCET INFECTIOUS DISEASES
- Antigenically Distinct MF59-Adjuvanted Vaccine to Boost Immunity to H5N1
- (2008) Iain Stephenson et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell Culture
- (2008) Hartmut J. Ehrlich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Immunogenicity of a Prepandemic Influenza A (H5N1) Vaccine in Children
- (2008) Zoltan Vajo et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Broad Clade 2 Cross-Reactive Immunity Induced by an Adjuvanted Clade 1 rH5N1 Pandemic Influenza Vaccine
- (2008) Isabel Leroux-Roels et al. PLoS One
- Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine
- (2008) Benoît Baras et al. PLoS One
- Safety, Humoral and Cell Mediated Immune Responses to Two Formulations of an Inactivated, Split-Virion Influenza A/H5N1 Vaccine in Children
- (2008) Tawee Chotpitayasunondh et al. PLoS One
- Safety and Immunogenicity of H5N1 Influenza Vaccine Based on Baculovirus Surface Display System of Bombyx mori
- (2008) Rongzhong Jin et al. PLoS One
- Modeling targeted layered containment of an influenza pandemic in the United States
- (2008) M. E. Halloran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The pandemic influenza vaccine challenge
- (2008) Marie Paule Kieny et al. VACCINE
- Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults
- (2008) Terry M. Nolan et al. VACCINE
- Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial
- (2008) Hans C. Rümke et al. VACCINE
- Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children
- (2008) Terry Nolan et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now